Breaking News

Lonza Expands Capsule Mfg. Capacity

$93 million investment to expand production capacity of capsules in CHI's Capsugel portfolio by 30 billion capsules annually, or 15%.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Lonza is investing $93 million in its Capsules and Health Ingredients (CHI) Division, a dosage form delivery partner to the biopharma and health nutrition industry. The investment will enable the company to expand its overall production capacity of capsules within CHI’s Capsugel portfolio by 30 billion capsules annually, maintaining Lonza’s Sigma Series quality standards. Production capacity will be increased across Lonza’s global manufacturing and supply chain network and will...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters